COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer (CROSS-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01651026
Recruitment Status : Unknown
Verified July 2017 by National Cancer Institute, Naples.
Recruitment status was:  Recruiting
First Posted : July 26, 2012
Last Update Posted : July 17, 2017
Information provided by (Responsible Party):
National Cancer Institute, Naples

Brief Summary:
The purpose of this study is to describe the diagnostic and treatment procedures employed for patients with rectal cancer in each participating center. Outcomes to treatment, costs of treatment will be described. Exploratory analyses will be done to identify factor that influence patient prognosis, as well as factors that predict patient response to treatment.

Condition or disease
Metastatic Colorectal Cancer

Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Multicentered Observational Prospective Cohort Study on Multidisciplinary Treatment of Rectal Cancer
Study Start Date : January 2011
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : November 2017

rectal cancer

Primary Outcome Measures :
  1. list of diagnostic procedures used in clinical practice, according to participating Institute [ Time Frame: 5 years ]

Other Outcome Measures:
  1. all treatments received for colorectal cancer (surgery, radiation therapy, chemotherapy, supportive care, etc) per patient [ Time Frame: 5 years ]
  2. rectal cancer surgical interventions/approaches per participating center [ Time Frame: 5 years ]
  3. disease outcomes per patient per treatment received [ Time Frame: 5 years ]
  4. estimated costs per treatment pattern per center [ Time Frame: 5 years ]
  5. factors that influence patient prognosis [ Time Frame: 5 years ]
    exploratory analyses

  6. predictive factors for response to treatment [ Time Frame: 5 years ]
    exploratory analyses

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Consecutive patients at participating Institutes with confirmed diagnosis of colorectal cancer.

Inclusion Criteria:

  • Histologic diagnosis rectal carcinoma
  • Signed informed consent

Exclusion Criteria:

  • Refusal or incapability of providing informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01651026

Layout table for location contacts
Contact: Francesco Perrone, M.D., Ph.D. +39 081 5903571
Contact: Marilina Piccirillo, M.D. +39 081 5903383

Layout table for location information
A.O.R.N. V. Monaldi Recruiting
Napoli, Italy
A.O.U. Federico II Recruiting
Napoli, Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico Recruiting
Napoli, Italy
Sponsors and Collaborators
National Cancer Institute, Naples
Layout table for investigator information
Principal Investigator: G. Romano, M.D. National Cancer Institute, Naples
Principal Investigator: C. Sassaroli, M.D. National Cancer Institute, Naples
Principal Investigator: M. C. Piccirillo, M.D. National Cancer Institute, Naples
Principal Investigator: Francesco Perrone, M.D., Ph.D National Cancer Institute, Naples
Layout table for additonal information
Responsible Party: National Cancer Institute, Naples Identifier: NCT01651026    
Other Study ID Numbers: CROSS-1
First Posted: July 26, 2012    Key Record Dates
Last Update Posted: July 17, 2017
Last Verified: July 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Rectal Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases